PL
PL · PL · PL-100381766
Glyxambi
ATC A10BD19
Last synced from URPL (Poland) on
Identification
ManufacturerBoehringer Ingelheim International GmbH
CountryPL (PL)
ATC codeA10BD19
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 9
- gtin05909991308544
- gtin05909991308551
- gtin05909991308568
- gtin05909991308575
- gtin05909991308582
- gtin05909991308599
- gtin05909991308605
- gtin05909991308612
- gtin05909991308629
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "10 mg + 5 mg",
"packaging": "05909991308544 ¦ Rp ¦ EU/1/16/1146/001 ¦ 119368\n7 tabl.\n05909991308551 ¦ Rp ¦ EU/1/16/1146/002 ¦ 119369\n10 tabl.\n05909991308568 ¦ Rp ¦ EU/1/16/1146/003 ¦ 119370\n14 tabl.\n05909991308575 ¦ Rp ¦ EU/1/16/1146/004 ¦ 119371\n28 tabl.\n05909991308582 ¦ Rp ¦ EU/1/16/1146/005 ¦ 119372\n30 tabl.\n05909991308599 ¦ Rp ¦ EU/1/16/1146/006 ¦ 119373\n60 tabl.\n05909991308605 ¦ Rp ¦ EU/1/16/1146/007 ¦ 119374\n70 tabl.\n05909991308612 ¦ Rp ¦ EU/1/16/1146/008 ¦ 119375\n90 tabl.\n05909991308629 ¦ Rp ¦ EU/1/16/1146/009 ¦ 119376\n100 tabl.",
"substance": "Empagliflozinum 10 mg + Linagliptinum 5 mg",
"common_name": "Empagliflozinum + Linagliptinum",
"pl_product_id": "100381766",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code A10BD19.
- NOGlyxambiBoehringer Ingelheim International GmbH
- 🇨🇭Glyxambi
- PLGlyxambiBoehringer Ingelheim International GmbH
- 🇨🇭GlyxambiBoehringer Ingelheim (Schweiz) GmbH
- DKGlyxambiBoehringer Ingelheim Int. GmbH
- ISGlyxambiBoehringer Ingelheim International GmbH*
- ISGlyxambiBoehringer Ingelheim International GmbH*
- NOGlyxambiBoehringer Ingelheim International GmbH
Access this data programmatically
Query Glyxambi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.